🧬 TB‑500 (5mg / 10mg) — High‑Purity Thymosin Beta‑4 Peptide Fragment for Cellular‑Migration, Angiogenesis & Tissue‑Modeling Research (Canada‑Wide)

TB‑500 is a high‑purity, research‑grade synthetic peptide fragment modeled after a functional region of Thymosin Beta‑4 (Tβ4), a naturally occurring actin‑binding protein involved in cellular migration, angiogenesis, and tissue‑remodeling pathways.

Widely referenced in Canadian laboratory environments, TB‑500 is used in in‑vitro and preclinical research exploring cytoskeletal dynamics, cell‑motility mechanisms, vascular‑growth signaling, and multi‑pathway tissue‑modeling systems.

Available in 5mg and 10mg fills, TB‑500 is engineered for mechanistic reproducibility, high stability, and broad applicability across cellular‑biology and regenerative‑signaling research.

🔍 What Is TB‑500?

TB‑500 is a synthetic peptide fragment derived from the active region of Thymosin Beta‑4, a protein known for its involvement in:

• Actin‑binding and cytoskeletal organization

• Cellular migration and motility pathways

• Angiogenesis and vascular‑growth signaling

• Tissue‑modeling and structural‑remodeling environments

• Stress‑response and cellular‑repair signaling

In research settings, TB‑500 is used to study:

• Actin‑modulating mechanisms

• Fibroblast migration and cytoskeletal dynamics

• Vascular‑growth and angiogenesis models

• Cellular‑resilience and stress‑adaptation pathways

• Comparative analysis vs. full‑length Thymosin Beta‑4

Its compact structure and mechanistic specificity make TB‑500 a widely used model compound for regenerative‑biology, cytoskeletal‑research, and tissue‑modeling studies across Canada.

📡 Mechanistic Overview (Audit‑Safe)

🔷 Actin‑Binding & Cytoskeletal Dynamics

• Referenced in studies involving actin‑modulating pathways

• Supports mapping of cellular‑migration mechanisms

• Used in models examining cytoskeletal organization

🔶 Cellular‑Migration & Motility Pathways

• Applied in fibroblast‑migration and wound‑modeling research

• Supports investigations into cell‑motility signaling

• Used in multi‑pathway tissue‑remodeling studies

🔵 Angiogenesis & Vascular‑Growth Signaling

• Examined in vascular‑growth and endothelial‑cell models

• Supports peptide‑mediated angiogenesis research

• Used in comparative studies vs. other regenerative peptides

🟣 Stress‑Response & Tissue‑Modeling

• Referenced in oxidative‑stress and cellular‑resilience assays

• Supports modeling of tissue‑remodeling environments

• Used in multi‑axis regenerative‑signaling investigations

🧱 Structural Overview

🧪 Molecular Composition

• Type: Synthetic peptide fragment of Thymosin Beta‑4

• Form: Lyophilized powder (5mg / 10mg fills)

• Identity: Verified via MS and HPLC/UPLC

• Origin: Derived from the actin‑binding region of Tβ4

🧬 Functional Domains

• Actin‑modulation domain: Cytoskeletal‑pathway research

• Migration domain: Fibroblast‑motility and tissue‑modeling studies

• Angiogenesis domain: Vascular‑growth signaling

🎯 Pathway Targets

• Actin‑binding and cytoskeletal networks

• Cellular‑migration and motility pathways

• Angiogenesis and endothelial‑cell signaling

• Tissue‑remodeling and structural‑repair cascades

• Peptide–protein interaction models

🔬 Research Focus Areas

TB‑500 is referenced in research involving:

• Cytoskeletal‑dynamics and actin‑binding assays

• Fibroblast‑migration and cellular‑motility studies

• Angiogenesis and vascular‑growth modeling

• Tissue‑remodeling and structural‑biology research

• Stress‑response and oxidative‑marker analysis

• Comparative regenerative‑peptide investigations

Its clean mechanistic profile makes it suitable for controlled, pathway‑specific research environments across Canada.

🧊 Stability & Biochemical Notes

• Highly stable in lyophilized form

• Sensitive to hydrolysis once reconstituted

• Avoid prolonged exposure to room temperature

• Avoid repeated freeze–thaw cycles

• Use sterile technique during preparation

❄️ Storage & Handling

• Store lyophilized peptide at –20°C, protected from light and humidity

• Reconstituted solutions should be stored at 2–8°C

• Use promptly after reconstitution

• Maintain sterile technique during preparation

🇨🇦 Optimized for Canadian Research Environments

BlueNexLabs supplies TB‑500 to research institutions across:

Vancouver • Toronto • Montreal • Calgary • Edmonton • Ottawa • Canada‑Wide

Offering:

• High‑purity, COA‑verified peptide materials

• Audit‑safe RUO labeling

• Fast, Canada‑wide fulfillment

• Research‑focused support for cytoskeletal and regenerative‑biology studies

📄 Documentation & COA Visibility

Each batch includes:

• MS identity confirmation

• HPLC purity profile

• Solvent system details

• RUO‑only designation

All documentation is structured for audit‑safe compliance and laboratory reproducibility.

⚠️ Compliance Notice

TB‑500 is supplied for laboratory research only. Not for human or veterinary use. No therapeutic, regenerative, or performance‑related claims are made or implied.